Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 72, Issue 3, Pages 684-690Publisher
OXFORD UNIV PRESS
DOI: 10.1093/jac/dkw502
Keywords
-
Funding
- Janssen Pharmaceutica
- Baekeland PhD scholarship from the Flemish Institute for Scientific Technology, Belgium [IWT 130308]
- European Research Council Starting Grant INTERRUPTB [311725]
Ask authors/readers for more resources
Objectives: Resistance-associated variants (RAVs) in Rv0678, a regulator of the MmpS5-MmpL5 efflux pump, have been shown to lead to increased MICs of bedaquiline ( 2-to8-fold) and clofazimine (2- to 4-fold). The prevalence of these Rv0678 RAVs in clinical isolates and their impact on treatment outcomes are important factors to take into account in bedaquiline treatment guidelines. Methods: Baseline isolates from two bedaquiline MDR-TB clinical trials were sequenced for Rv0678 RAVs and corresponding bedaquiline MICs were determined on 7H11 agar. Rv0678 RAVs were also investigated in non-MDRTB sequences of a population-based cohort. Results: Rv0678 RAVs were identified in 23/347 (6.3%) of MDR-TB baseline isolates. Surprisingly, bedaquiline MICs for these isolates were high (> 0.24 mg/ L, n = 8), normal (0.03-0.24 mg/ L, n =11) or low(< 0.03 mg/ L, n = 4). A variant at position - 11 in the intergenic regionmmpS5- Rv0678 was identified in 39 isolates (11.3%) and appeared to increase the susceptibility to bedaquiline. In non-MDR-TB isolates, the frequency of Rv0678 RAVs was lower (6/852 or 0.7%). Competition experiments suggested that rifampicin was not the drug selecting for Rv0678 RAVs. Conclusions: RAVs in Rv0678 occurmore frequently in MDR-TB patients than previously anticipated, are not associated with prior use of bedaquiline or clofazimine, and in themajority of cases do not lead to bedaquiline MICs above the provisional breakpoint (0.24mg/L). Their origin remains unknown. Given the variety of RAVs in Rv0678 and their variable effects on the MIC, only phenotypic drug-susceptibilitymethods can currently be used to assess bedaquiline susceptibility.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available